Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser
Recruiting
N/A
Interventional Study
Immediate Post-Treatment Care
Aging Mid-Face
Aging
At a Glance
- Age
- 40 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 21 (estimated)
- Sponsor
- Lynch Regenerative Medicine · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
ariessence is intended to be used as a viscous, leave-on solution designed for topical application to the face. It is intended to be used following non-medical cosmetic procedures, performed by licensed healthcare professionals to enhance comfort and maintain skin hydration. This study is designed to be a multi-center, post-market cosmetic evaluation of ariessence applied to the full face after an…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
-:Adults 40-65 70 years
* Glogau III-IV
* Fitzpatrick II-IV.
* Suitable for ablative laser
* non-smoker ≥ 3 years
* Willing to comply with post-procedure regimen
* patient reported outcome documentation, and photo documentation.
Exclusion Criteria:
* Fitzpatrick I or \> IV,
* …
Contacts